Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Heart failure with midrange ejection fraction—what is it, if anything?.Can J Cardiol. 2021; 37: 585-594
- Angiotensin-neprilysin inhibition versus enalapril in heart failure.N Engl J Med. 2014; 371: 993-1004
- Sacubitril/valsartan across the spectrum of ejection fraction in heart failure.Circulation. 2020; 141: 352-361
- Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.Eur J Heart Fail. 2018; 20: 1230-1239
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.Eur Heart J. 2016; 37: 455-462
See page 529 for disclosure information.